5

PRIMARY DOCUMENT

Company: REGENERON PHARMACEUTICALS, INC.
Filed: January 5, 2006
Period of Report: December 31, 2005
Accession Number: 0001237899-06-000010

View Document ↗ View on SEC.gov ↗